Skip to main content
TipRanks
Go Ultimate75% OFF

Atrium Therapeutics, Inc. (RNA) Hedge Fund Trading Activity

25 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 938.1K Shares Last Quarter

Hedge Fund Holdings in RNA

0.00$6.00800.00K$8.751.60M$11.502.40M$14.253.20M$17.00Jul '26$6.48Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
Randal A. Nardone hedge funds manager, Fortress Investment Group LLC,Rank 469Randal A. NardoneFortress Investment Group LLCNew100.00%$165,6000.03%
BlackRock, Inc. hedge funds manager,  ,Rank 334BlackRock, Inc. Reduced-15.82%$10,089,362<0.01%
Bruce Winson hedge funds manager, Anson Funds Management LP,Rank 484Bruce WinsonAnson Funds Management LPSold Out-100.00%$00.00%
Boaz Weinstein hedge funds manager, Saba Capital Management,Rank 380Boaz WeinsteinSaba Capital ManagementSold Out-100.00%$00.00%

FAQ

Which hedge funds hold Atrium Therapeutics, Inc.?
The hedge funds that hold the most shares in Atrium Therapeutics, Inc. are BlackRock, Inc., Bruce Winson and Randal A. Nardone.
Are hedge funds buying or selling RNA?
In the last quarter hedge funds have Decreased their holdings in Atrium Therapeutics, Inc. by 938.1K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Atrium Therapeutics, Inc. stock?
Warren Buffet currently does not own shares in Atrium Therapeutics, Inc..
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here